Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple MyelomaAshraf Badros, Steven Grant, Angelika M. Burger et al.|Clinical Cancer Research|2009Cited by 230
Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T CellsAaron P. Rapoport, Carl H. June, Nicole A. Aqui et al.|Clinical Cancer Research|2014Cited by 123
Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemiaAshkan Emadi, Søren M. Bentzen, Jennie Y. Law et al.|Cancer Chemotherapy and Pharmacology|2017Cited by 53
Combination Immunotherapy After ASCT for Multiple Myeloma (MM) Using MAGE-A3/Poly-ICLC Immunizations Followed by Vaccine-Primed and Activated Autologous T-CellsAaron P. Rapoport, Carl H. June, Ling Cai et al.|Blood|2012Cited by 5
Supplementary Table 1 from Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T CellsAaron P. Rapoport, Carl H. June, Nicole A. Aqui et al.|Unknown|2023Cited by 0